Chemoinformaics analysis of cis-Limonene 1,2 oxide
| Molecular Weight | 186.339 | nRot | 7 |
| Heavy Atom Molecular Weight | 160.131 | nRig | 0 |
| Exact Molecular Weight | 186.198 | nRing | 0 |
| Solubility: LogS | -3.99 | nHRing | 0 |
| Solubility: LogP | 4.214 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 38.1786 |
| nHD | 0 | BPOL | 27.8194 |
| QED | 0.586 |
| Synth | 3.208 |
| Natural Product Likeliness | 1.067 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.108 |
| Pgp-sub | 0.019 |
| HIA | 0.002 |
| CACO-2 | -4.23 |
| MDCK | 0.0000172 |
| BBB | 0.378 |
| PPB | 0.927034 |
| VDSS | 1.349 |
| FU | 0.0415746 |
| CYP1A2-inh | 0.145 |
| CYP1A2-sub | 0.76 |
| CYP2c19-inh | 0.048 |
| CYP2c19-sub | 0.948 |
| CYP2c9-inh | 0.086 |
| CYP2c9-sub | 0.294 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.507 |
| CYP3a4-inh | 0.091 |
| CYP3a4-sub | 0.471 |
| CL | 9.822 |
| T12 | 0.214 |
| hERG | 0.04 |
| Ames | 0.008 |
| ROA | 0.019 |
| SkinSen | 0.48 |
| Carcinogencity | 0.153 |
| EI | 0.979 |
| Respiratory | 0.077 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.52804 |